The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
CYCLIZINE-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
CYCLIZINE-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
128 (255 working days)
Active ingredients
cyclizine lactate
Registration type
New generic medicine
Indication
Cyclizine-AFT is indicated for the prevention of nausea and vomiting in the post-operative period.